Marek Skarupski
Overview
Explore the profile of Marek Skarupski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
14
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Resler K, Lubieniecki P, Zatonski T, Doroszko A, Trocha M, Skarupski M, et al.
Microorganisms
. 2024 Oct;
12(10).
PMID: 39458369
Background: The aim of this study was to see if the CHADS-VASc score (Cardiac failure or dysfunction, Hypertension, Age ≥ 75 [Doubled], Diabetes, Stroke [Doubled]-Vascular disease, Age 65-74 and Sex...
2.
Karasek M, Armatys A, Skarupski M, Bolkun L, Budziszewska K, Drozd-Sokolowska J, et al.
Front Oncol
. 2024 Jun;
14:1395992.
PMID: 38835383
Introduction: Mixed-phenotype acute leukemia (MPAL) is a rare disease with poor prognosis. So far, no standard approach has been established as the "know-how" of MPAL is based only on retrospective...
3.
Sobas M, Knopinska-Posluszny W, Piatkowska-Jakubas B, Garcia-Alvarez F, Diez M, Caballero M, et al.
Ann Hematol
. 2023 Dec;
103(2):451-461.
PMID: 38110588
The most important challenges in acute promyelocytic leukemia (APL) is preventing early death and reducing long-term events, such as second neoplasms (s-NPLs). We performed a retrospective analysis of 2670 unselected...
4.
Sebastian A, Madziarski M, Madej M, Proc K, Szymala-Pedzik M, Zorawska J, et al.
Int J Environ Res Public Health
. 2022 Oct;
19(19).
PMID: 36231836
Background: The COVID-GRAM is a clinical risk rating score for predicting the prognosis of hospitalized COVID-19 infected patients. Aim: Our study aimed to evaluate the use of the COVID-GRAM score...
5.
Rola P, Doroszko A, Trocha M, Gajecki D, Gawrys J, Matys T, et al.
Viruses
. 2022 Aug;
14(8).
PMID: 36016394
Background: Even though coronary artery disease (CAD) is considered an independent risk factor of an unfavorable outcome of SARS-CoV-2-infection, the clinical course of COVID-19 in subjects with CAD is heterogeneous,...
6.
Rola P, Doroszko A, Trocha M, Giniewicz K, Kujawa K, Skarupski M, et al.
Viruses
. 2022 Mar;
14(3).
PMID: 35337035
Since the outbreak of the COVID-19 pandemic, a growing number of evidence suggests that COVID-19 presents sex-dependent differences in clinical course and outcomes. Nevertheless, there is still an unmet need...
7.
Rola P, Doroszko A, Trocha M, Giniewicz K, Kujawa K, Skarupski M, et al.
J Clin Med
. 2022 Feb;
11(4).
PMID: 35207272
Methods: We retrospectively analyzed 1047 medical records of patients at age > 65 years, hospitalized at the medical university center due to COVID-19. Subsequently, patients were divided into three categories...
8.
Gajecki D, Doroszko A, Trocha M, Giniewicz K, Kujawa K, Skarupski M, et al.
J Clin Med
. 2022 Feb;
11(3).
PMID: 35160324
Background: Diabetes mellitus is among the most frequent comorbidities worsening COVID-19 outcome. Nevertheless, there are no data regarding the optimal risk stratification of patients with diabetes and COVID-19. Since individual...